Document is current
Any future updates will be listed below
-
Authors
Shalmiev, A.
Nadeau, G.
Aaron, M.
Ouimet-Grennan, E.
Drouin, S.
Bertout, L. https://orcid.org/0000-0003-0120-7882
Beaulieu, P.
St-Onge, P.
Veilleux, L.-N. https://orcid.org/0000-0001-7672-8477
Rauch, F.
Rezgui, A.
Petrykey, K. https://orcid.org/0000-0002-5865-3907
Laverdière, C.
Sinnett, D. https://orcid.org/0000-0003-3625-6676
Alos, N.
Krajinovic, M. https://orcid.org/0000-0003-4772-7031
-
Funding
Funding for this research was provided by:
Gouvernement du Canada | Canadian Institutes of Health Research (118694, 118694, 118694, 118694, 118694, 118694, 118694, 118694, 118694, 118694, 118694, 118694, 118694, 118694, 118694)
- License Information
-
More Information
Article History
Received: 22 March 2021
Revised: 11 August 2021
Accepted: 17 August 2021
First Online: 26 August 2021
Competing interests
: AS worked at Phinc. Modeling as a pharmacokineticist. GN, MA, EOG, SD, LB, PB, PSO, LNV, FR, AR, KP, CL, SD, NA, and MK have nothing to disclose. All authors declare that they have no competing interests.
: Patients older than 18 years of age and parents of minor patients gave their written informed consent to participate in the study, which was approved by the Institutional Review Board of SJUHC. The study was conducted in accordance with the Declaration of Helsinki.
